SFM
ITCI

Sphera Funds Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sphera Funds Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-48,400
Closed -$2.6M – 125
2015
Q4 		$2.6M Sell
48,400
-57,000
-54% -$2.88M 0.38% 68
2015
Q3 		$4.22M Sell
105,400
-22,600
-18% -$737K 0.54% 35
2015
Q2 		$4.09M Sell
128,000
-22,000
-15% -$558K 0.4% 56
2015
Q1 		$3.58M Buy
+150,000
New +$3.36M 0.37% 66
2014
Q3 		– Sell
-94,300
Closed -$1.59M – 148
2014
Q2 		$1.59M Sell
94,300
-5,700
-6% -$94.2K 0.39% 61
2014
Q1 		$1.82M Buy
+100,000
New +$1.81M 0.42% 50

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sphera Funds Management's ITCI Position: Q1 2016 in Review

Sphera Funds Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2016, closing a stake of 48,400 shares — an estimated $2.6M sold.

Sphera Funds Management first reported a position in ITCI in Q1 2014 and held it in 6 quarters. The position peaked at $4.22M in Q3 2015. 127 funds tracked by Wall St. Rank hold ITCI as of Q1 2016.

  • Sphera Funds Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 48,400 Intra-Cellular Therapies Inc. shares in Q1 2016, an estimated $2.6M.
  • Sphera Funds Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2014 and held it in 6 quarters.
  • Sphera Funds Management's Intra-Cellular Therapies Inc. position peaked at $4.22M in Q3 2015.
  • 127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.